Top Pharmaceuticals companies in Netherlands by Operating Income Margin

This ranking features the top 8 Pharmaceuticals companies in Netherlands ranked by Operating Income Margin, averaging a Operating Income Margin of -575.74%, for February 07, 2025.
#
Name
Operating Income Margin
Reported Date
Stock Price
Change
Price (30 days) Country
1
-0.96%
Dec. 31, 2023 USD 129.11 4.28%

Netherlands

2
-1.99%
Dec. 31, 2023 USD 8.76 -0.46%

Netherlands

3
-34.66%
Dec. 31, 2023 USD 667.09 1.81%

Netherlands

4
-356.22%
Dec. 31, 2023 USD 40.94 -1.52%

Netherlands

5
-489.09%
Dec. 31, 2023 USD 2.12 -1.40%

Netherlands

6
-638.99%
Dec. 31, 2023 USD 0.98 -1.01%

Netherlands

7
-1,298.56%
Dec. 31, 2023 USD 22.29 2.39%

Netherlands

8
-1,785.46%
Dec. 31, 2023 USD 15.74 -0.32%

Netherlands

Frequently Asked Questions
  • Which Pharmaceuticals company in Netherlands has the highest Operating Income Margin ?

    The Pharmaceuticals company in Netherlands with the highest Operating Income Margin is Redcare Pharmacy NV (XETRA: RDC.DE) at -0.96%.

  • Which Pharmaceuticals company in Netherlands has the lowest Operating Income Margin ?

    The Pharmaceuticals company in Netherlands with the lowest Operating Income Margin is uniQure N.V. (NasdaqGS: QURE) at -1,785.46%.

SV Wall Street